Post-stroke cognitive impairment and dementia
Poststroke cognitive impairment and dementia (PSCID) is a major source of morbidity and
mortality after stroke worldwide. PSCID occurs as a consequence of ischemic stroke …
mortality after stroke worldwide. PSCID occurs as a consequence of ischemic stroke …
Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association
Purpose: Cognitive impairment is a common consequence of stroke and has direct
implications for poststroke functioning and quality of life, including the ability to maintain a …
implications for poststroke functioning and quality of life, including the ability to maintain a …
[HTML][HTML] Vascular cognitive impairment (VCI)
Vascular cognitive impairment (VCI) is predominately caused by vascular risk factors and
cerebrovascular disease. VCI includes a broad spectrum of cognitive disorders, from mild …
cerebrovascular disease. VCI includes a broad spectrum of cognitive disorders, from mild …
European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment
TJ Quinn, E Richard, Y Teuschl… - European stroke …, 2021 - journals.sagepub.com
The optimal management of post-stroke cognitive impairment remains controversial. These
joint European Stroke Organisation (ESO) and European Academy of Neurology (EAN) …
joint European Stroke Organisation (ESO) and European Academy of Neurology (EAN) …
Long-term effects of cholinesterase inhibitors on cognitive decline and mortality
Objective To investigate whether cholinesterase inhibitors (ChEIs) are associated with
slower cognitive decline in Alzheimer dementia and decreased risk of severe dementia or …
slower cognitive decline in Alzheimer dementia and decreased risk of severe dementia or …
ESO Guideline on covert cerebral small vessel disease
JM Wardlaw, S Debette, H Jokinen… - European Stroke …, 2021 - journals.sagepub.com
'Covert'cerebral small vessel disease (ccSVD) is common on neuroimaging in persons
without overt neurological manifestations, and increases the risk of future stroke, cognitive …
without overt neurological manifestations, and increases the risk of future stroke, cognitive …
Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
SY Cheon, J Song - Cell & Bioscience, 2022 - Springer
Non-alcoholic fatty liver disease (NAFLD) is a metabolic disease characterized by multiple
pathologies. The progression of dementia with NAFLD may be affected by various risk …
pathologies. The progression of dementia with NAFLD may be affected by various risk …
Cognitive impairment in older adults: epidemiology, diagnosis, and treatment
NP Palmer, BT Ortega, P Joshi - Psychiatric Clinics, 2022 - psych.theclinics.com
With an increasingly aging population, health care providers will treat a higher number of
patients with cognitive impairment. Identifying cognitive impairment and intervening early …
patients with cognitive impairment. Identifying cognitive impairment and intervening early …
Aromatherapy for dementia
LT Forrester, N Maayan, M Orrell… - Cochrane Database …, 2014 - cochranelibrary.com
Background Complementary therapy has received great interest within the field of dementia
treatment and the use of aromatherapy and essential oils is increasing. In a growing …
treatment and the use of aromatherapy and essential oils is increasing. In a growing …
[HTML][HTML] Cerebral small vessel disease–related dementia: more questions than answers
FM Elahi, MM Wang, JF Meschia - Stroke, 2023 - journals.lww.com
Cerebral small vessel disease (CSVD) has emerged as a common factor driving age-
dependent diseases, including stroke and dementia. CSVD-related dementia will affect a …
dependent diseases, including stroke and dementia. CSVD-related dementia will affect a …